NNVC
Income statement / Annual
Last year (2024), NanoViricides, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, NanoViricides, Inc.'s net income was -$8.29 M.
See NanoViricides, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$759,014.00 |
$747,529.00 |
$723,325.00 |
$704,538.00 |
$699,724.00 |
$695,911.00 |
$680,058.00 |
$662,954.00 |
$659,545.00 |
$0.00 |
| Gross Profit |
-$759,014.00 |
-$747,529.00 |
-$723,325.00 |
-$704,538.00 |
-$699,724.00 |
-$695,911.00 |
-$680,058.00 |
-$662,954.00 |
-$659,545.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$5.44 M
|
$6.39 M
|
$5.78 M
|
$6.11 M
|
$4.70 M
|
$5.92 M
|
$4.83 M
|
$5.53 M
|
$5.03 M
|
$3.66 M
|
| General & Administrative
Expenses |
$3.08 M
|
$2.55 M
|
$2.33 M
|
$2.63 M
|
$3.30 M
|
$2.74 M
|
$4.50 M
|
$4.07 M
|
$3.83 M
|
$3.40 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$3.08 M
|
$2.55 M
|
$2.33 M
|
$2.63 M
|
$3.30 M
|
$2.74 M
|
$4.50 M
|
$4.07 M
|
$3.83 M
|
$3.40 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
-$142,669.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$8.52 M |
$8.94 M |
$8.11 M |
$8.74 M |
$8.00 M |
$8.66 M |
$9.33 M |
$9.60 M |
$8.86 M |
$7.06 M |
| Cost And Expenses |
$8.52 M |
$8.94 M |
$8.11 M |
$8.74 M |
$8.00 M |
$8.66 M |
$9.33 M |
$9.60 M |
$8.86 M |
$7.06 M |
| Interest Income |
$221,965.00 |
$355,833.00 |
$11,859.00 |
$9,348.00 |
$17,079.00 |
$55,497.00 |
$100,429.00 |
$60,955.00 |
$62,638.00 |
$160,859.00 |
| Interest Expense |
$0.00 |
$938.00 |
$5,123.00 |
$85,405.00 |
$93,670.00 |
$0.00 |
$544,488.00 |
$2.13 M |
$2.47 M |
$3.82 M |
| Depreciation &
Amortization |
$759,014.00
|
$747,529.00
|
$723,325.00
|
$704,538.00
|
$699,724.00
|
$695,911.00
|
$680,058.00
|
$662,954.00
|
$659,545.00
|
$302,738.00
|
| EBITDA |
-$7.76 M
|
-$7.84 M
|
-$7.38 M
|
-$8.03 M
|
-$7.30 M
|
-$7.96 M
|
-$8.59 M
|
-$8.94 M
|
-$8.20 M
|
-$6.76 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$221,965.00
|
$354,895.00
|
$6,736.00
|
-$78,083.00
|
-$5.45 M
|
$235,242.00
|
$761,714.00
|
-$703,766.00
|
-$1.87 M
|
$4.86 M
|
| Income Before Tax |
-$8.29 M |
-$8.59 M |
-$8.11 M |
-$8.82 M |
-$13.45 M |
-$8.42 M |
-$8.56 M |
-$10.30 M |
-$10.72 M |
-$2.20 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
$355,833.00 |
-$6,736.00 |
$85,405.00 |
-$48,999.00 |
-$179,745.00 |
$1.31 M |
$2.13 M |
$2.47 M |
$3.82 M |
| Net Income |
-$8.29 M |
-$8.59 M |
-$8.10 M |
-$8.91 M |
-$13.40 M |
-$8.24 M |
-$8.56 M |
-$10.30 M |
-$10.72 M |
-$2.20 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.7 |
-0.74 |
-0.7 |
-0.82 |
-2.39 |
-2.3 |
-2.64 |
-3.43 |
-3.72 |
-0.78 |
| EPS Diluted |
-0.7 |
-0.74 |
-0.7 |
-0.82 |
-2.39 |
-2.3 |
-2.64 |
-3.43 |
-3.72 |
-0.74 |
| Weighted Average Shares
Out |
$11.87 M
|
$11.63 M
|
$11.53 M
|
$10.90 M
|
$5.62 M
|
$3.59 M
|
$3.25 M
|
$3.01 M
|
$2.88 M
|
$2.83 M
|
| Weighted Average Shares
Out Diluted |
$11.87 M
|
$11.63 M
|
$11.53 M
|
$10.90 M
|
$5.62 M
|
$3.59 M
|
$3.25 M
|
$3.01 M
|
$2.88 M
|
$2.96 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
